BIOTRONIK - Safety and Performance Registry for an all-comers patient population with the Limus Eluting Orsiro Stent System Within daily clinical practice - III (UK & Ireland Satellite)

Trial Profile

BIOTRONIK - Safety and Performance Registry for an all-comers patient population with the Limus Eluting Orsiro Stent System Within daily clinical practice - III (UK & Ireland Satellite)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BIOFLOW III
  • Most Recent Events

    • 29 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top